etoricoxib

Known as: 5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine, 5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl, 5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine 
A synthetic, nonsteroidal anti-inflammatory drug (NSAID) with antipyretic, analgesic, and potential antineoplastic properties. Etoricoxib… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2017
0204020012017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
BACKGROUND Population mean changes from clinical trials are difficult to apply to individuals in clinical practice. Responder… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2009
2009
OBJECTIVE To describe and assess the response to short-term etoricoxib as shown by MRI and clinical variables in patients with… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Upper gastrointestinal safety of cyclo-oxygenase (COX)-2 selective inhibitors versus traditional non-steroidal anti… (More)
Is this relevant?
2007
2007
OBJECTIVE . To compare the gastrointestinal (GI) tolerability, safety, and efficacy of etoricoxib and diclofenac in patients with… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
BACKGROUND Cyclo-oxygenase-2 (COX-2) selective inhibitors have been associated with an increased risk of thrombotic… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
 
Is this relevant?
2004
2004
OBJECTIVE To evaluate the efficacy and safety of etoricoxib and indomethacin in the treatment of patients with acute gout… (More)
Is this relevant?
2003
2003
Etoricoxib is a potent selective COX-2 inhibitor in man. Ex vivo whole-blood assays assessed COX-2 inhibition after oral… (More)
Is this relevant?
2003
2003
OBJECTIVE:Etoricoxib is a selective cyclooxygenase inhibitor that in clinical studies has improved the signs and symptoms of… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
We report here the preclinical profile of etoricoxib (MK-0663) [5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?